Treatment Options for Patients with Recurrent Endometrial Cancer

Emetogenic chemotherapy regimens and back pain were associated with higher symptom burden in older, vs younger, patients with cancer.

Lauren Mahon, MSN, FNP-BC, breaks down what oncology nurses should know about PARP inhibitors in ovarian cancer.

Oncology nurses can support patients facing financial toxicity by offering guidance on available resources and providing emotional support.

In this episode of The Vitals, we recount the oncology drugs that received FDA approvals in 2022.

Oncology nurses can enhance endometrial cancer recovery by fostering strong social support networks and improving communication with the patient.

Biocartis announced the launch of its real-time quantitative polymerase chain reaction assay to detect POLE and POLD1 mutations in endometrial cancer.